Clinical Trials Logo

Filter by:
NCT ID: NCT04943965 Completed - Clinical trials for This Study is Being Conducted to Collect Echocardiographic Data to Test the Lumify Ultrasound With Hemodynamic Automation Device

Testing Automated Echocardiography

Start date: August 11, 2021
Phase:
Study type: Observational

The purpose of this research is to determine if software can accurately predict certain heart parameters from chest wall ultrasound (non-radiation, non-invasive, imaging modality). An approved ultrasound device (Lumify) will be used to obtain images prior to cardiac surgery.

NCT ID: NCT04943887 Completed - Multiple Sclerosis Clinical Trials

CONNECT Trial of eSupport Online Health-coach Moderated Support Groups for Multiple Sclerosis

CONNECT
Start date: August 1, 2021
Phase: N/A
Study type: Interventional

Within-subject waitlist-control group design trial of eSupport health-coach moderated online support group participation to address mental health needs in persons with multiple sclerosis (PwMS) from historically underrepresented groups (i.e., Black and Latinx patients).

NCT ID: NCT04943835 Completed - Clinical trials for Acquired Brain Injury

Validity of a Test of Functional Cognition in Persons With Acquired Brain Injury

Start date: January 12, 2017
Phase:
Study type: Observational

The purpose of this study is to test the validity of the Weekly Calendar Planning Activity (WCPA), a test of functional cognition in persons with acquired brain injury. We will formally examine the utility, baseline profile and validity of the WCPA with adults ages 21 and above with acquired brain injury for both the WCPA 17 and WCPA 10 versions.

NCT ID: NCT04943575 Completed - Common Cold Clinical Trials

Study to Evaluate the Efficacy of EZC Pak in Adults With Upper Respiratory Infection (URI)

Start date: June 1, 2021
Phase: N/A
Study type: Interventional

A randomized-controlled interventional clinical trial to evaluate the effectiveness of EZC Pak & EZC Pak+D for the treatment of the common cold and/or a URI.

NCT ID: NCT04943432 Completed - Clinical trials for Intravenous Drug Usage

Open Trial of a Behavioral Activation Telepsychology Intervention for People Who Inject Drugs

Start date: September 29, 2021
Phase: N/A
Study type: Interventional

The study has two aims: 1) To examine the feasibility and acceptability of administering a telepsychology Behavioral Activation (BA) treatment for substance use among non-treatment-seeking people who inject drugs (PWID); 2) To test the initial efficacy of the treatment from pretreatment to a 1-month follow-up on substance-related problems, readiness to change drug use, and BA. The intervention is hypothesized to be feasible and well-accepted, and within-subject analyses are hypothesized to demonstrate decreases in substance-related problems and increases in readiness to change drug use and BA from pretreatment to a 1-month follow-up. The study aims to recruit N=25 non-treatment-seeking PWID from a syringe exchange program (estimated treated sample n=15). Participants will receive 8 sessions of BA over 4 weeks, and assessment of study outcome measures will occur at pretreatment, post-treatment, and a one-month follow-up.

NCT ID: NCT04943393 Completed - Phenylketonurias Clinical Trials

Remote Neurocognitive and Psychological Assessment in PKU

Start date: November 24, 2020
Phase:
Study type: Observational

PKU is a rare autosomal recessive condition associated with disruption in dopamine synthesis. Although early diagnosis and treatment prevent the severe impairments associated with untreated PKU, individuals with early-treated PKU (ETPKU) nonetheless experience significant sequelae, including impaired working memory and increased risk for anxiety problems. Past research with other clinical populations (e.g., generalized anxiety disorder) suggests that the two phenomena may be linked, with increased anxiety contributing to poorer WM performance. Currently we propose to initiate an exciting new line of research examining the potential relationship between anxiety and WM in ETPKU. The proposed study will also apply remote neuropsychological performance-based assessment to the study of ETPKU and thus overcoming the geographical limitations/challenges associated with recruitment of participants with this rare disease.

NCT ID: NCT04942964 Completed - Healthy Volunteers Clinical Trials

A Study to Evaluate ASP0367 in Participants With Mild/Moderate Hepatic Impairment Compared to Participants With Normal Hepatic Function

Start date: September 13, 2021
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the effect of ASP0367 in participants with mild and moderate hepatic impairment compared to healthy participants with normal hepatic function. The study will also evaluate the safety and tolerability of ASP0367 in participants with mild and moderate hepatic impairment compared to healthy participants with normal hepatic function.

NCT ID: NCT04942938 Completed - Multiple Sclerosis Clinical Trials

Impact of Direct Current Electrical Stimulation on Spasticity Levels and Functional Muscle Use in MS

Start date: June 20, 2021
Phase: N/A
Study type: Interventional

In an individual with MS the central nervous system (CNS) is over-protective and causes the threshold for stretch reflex and muscle tightness to be set lower than normal. This inhibits normal movement and causes abnormalities in posture, stiffness and at times joint contractures. In this pilot study we hope to assess the ability for the direct current of Neubie, which creates mechanoreceptor inputs and lengthening at the sarcomere level of muscle and joints in the spine and lower extremity, to alter the proprioceptive peripheral nervous system (PNS) at muscle spindle and GTO level with a change in CNS over-guarding during the treatment and after the treatment. If the investigators are able to create normalized stretch and muscle tension at the PNS level, it may be possible to create temporary or sustained CNS level changes. This would allow the amount of stretch and tension at the PNS level to be normalized and possibly reduce spasticity. If this theory is accurate, the investigators may be able to increase access to normalized movement, strength and functional ability in individuals with neuro-compromise.

NCT ID: NCT04942925 Completed - Myopia Clinical Trials

Clinical Comparison of Two Daily Disposable Contact Lenses - Pilot Study 3

Start date: July 20, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the overall performance of PRECISION1™ contact lenses when compared to INFUSE™ contact lenses.

NCT ID: NCT04942678 Completed - Anxiety Clinical Trials

The Impact of Therapy Dogs on Anxiety and Emotional Management in the Pediatric Emergency Department

Start date: May 25, 2021
Phase:
Study type: Observational

The purpose of this study is to assess the impact of therapy dogs on children's anxiety and emotional management during a visit to the pediatric emergency department.